Orkambi
(asked on 5th December 2016) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what discussions his Department has had with Vertex on bringing Orkambi to the market.
This question was answered on 13th December 2016
It is for a manufacturer to decide when to market their product.
Vertex received a Marketing Authorisation for Orkambi (lumacaftor-ivacaftor) for the treatment of cystic fibrosis in November 2015. The National Health Service list price for Orkambi was agreed with Departmental officials in December 2015 and the product was launched in the United Kingdom in May 2016.